Gene expression in colorectal cancer.

Area of Science:

• Genomics
• Molecular Biology
• Oncology

Background:

• Understanding molecular alterations in colorectal cancer (CRC) is crucial for identifying novel biomarkers and therapeutic targets.
• Gene expression profiling provides insights into the complex molecular landscape of cancer.

Purpose of the Study:

• To identify genes and expressed sequence tags (ESTs) with significant alterations in sporadic colorectal carcinomas compared to normal tissue.
• To discover potential new biomarkers and therapeutic targets for CRC.

Main Methods:

• Oligonucleotide microarrays were used to analyze gene expression in pooled RNA from left-sided sporadic colorectal carcinomas (Dukes' stages A-D) and normal tissue.
• Intensive filtering and cluster analysis were applied to identify relevant genes and ESTs.
• Real-time PCR was used to validate array-based findings.

Main Results:

• 908 known genes and 4,155 ESTs showed remarkable changes between normal and tumor tissues.
• 226 known genes and 157 ESTs were identified as highly relevant for CRC.
• Gene expression patterns clustered normal tissue with Dukes' A, Dukes' B with C, and Dukes' D separately.
• Altered genes were frequently associated with metabolism, transcription, translation, and cellular processes.
• Fifteen nuclear-encoded mitochondrial proteins were consistently down-regulated in CRC.
• Specific chromosomal locations showed clusters of potential oncogenes or tumor suppressors, with some correlating with loss of heterozygosity.

Conclusions:

• The study identified numerous genes and ESTs with significant alterations in colorectal cancer.
• These findings highlight potential novel biomarkers and therapeutic targets for CRC.
• The identified molecular signatures may aid in understanding CRC progression and developing targeted therapies.